Vyvanse is effective in treating adults with attention-deficit/hyperactivity disorder, according to new clinical trial results. In the study, 414 adults ages 18 to 55 who took the med daily for four weeks showed improvement in core ADHD symptoms, according to Shire. The Food and Drug Administration has already approved Vyvanse for the treatment of ADHD in children.
Read moreLast week I wrote a post entitled, "Why Some People Don't Believe in ADHD" which generated a lot of discussion among our members on ADHD... Read more »
My Attention Deficit Hyperactivity Disorder (ADHD) wasn't diagnosed till I was in my late thirties. By that point, as you can imagine, I... Read more »
I let the most bizarre things fall through the cracks. At home it's usually something small, like when I was steeping herbs in olive oil,... Read more »
Welcome Terry Matlen Terry Matlen, author of "Survival Tips for Women with ADHD" and director of ADD Consults, has joined Health... Read more »
In case you were not aware, ADHD Awareness Week (September 14-20) is happening right now as we speak. One purpose of such a promotional... Read more »
Shire, the maker of Vyvanse, has filed for U.S. approval to treat adult attention-deficit/hyperactivity disorder with their new ADHD medication.... Read more »
The U.S. Food and Drug Administration has approved Vyvanse for the treatment of attention-deficit/hyperactivity disorder in adults. Vyvanse is a new... Read more »
According to the drug manufacturer Shire, the Food and Drug Administration has approved Vyvanse for the treatment of attention-deficit/hyperactivity... Read more »
Brand Name: Focalin and Focalin XR Generic Name: dexmethylphenidate hydrochloride Usage Focalin is a short acting stimulant medication and is... Read more »
Source: ADAM Encyclopedia
Stimulant Medications and Heart RisksAll ADHD stimulant drugs carry warnings that they should not be used by patients with structural heart problems... Read more »